Malinoski Darren J, Ewing Tyler, Patel Madhukar S, Nguyen David, Le Tony, Cui Eric, Kong Allen, Dolich Matthew, Barrios Cristobal, Cinat Marianne, Lekawa Michael, Salim Ali
Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
J Trauma. 2011 Aug;71(2):316-21; discussion 321-2. doi: 10.1097/TA.0b013e318222f3f4.
The natural history and optimal treatment of upper extremity (UE) deep venous thromboses (DVT's) remains uncertain as does the clinical significance of catheter-associated (CA) UE DVT's. We sought to analyze predictors of UE DVT resolution and hypothesized that anticoagulation will be associated with quicker UE DVT clot resolution and that CA UE DVT's whose catheters are removed will resolve more often than non-CA UE DVT's.
All patients on the surgical intensive care unit service were prospectively followed from January 2008 to May 2010. A standardized DVT prevention protocol was used and screening bilateral UE and lower extremity duplex examinations were obtained within 48 hours of admission and then weekly. Computed tomography angiography for pulmonary embolism was obtained if clinically indicated. Patients with UE DVT were treated according to attending discretion. Data regarding patient demographics and UE DVT characteristics were recorded: DVT location, catheter association, occlusive status, treatment, and resolution. The primary outcome measure was UE DVT resolution before hospital discharge. Interval decrease in size on the subsequent duplex after UE DVT detection was also noted. UE DVTs without a follow-up duplex were excluded from the final analysis. Univariate and multivariate analyses were used to identify independent predictors of UE DVT resolution.
There were 201 UE DVT's in 129 patients; 123 DVTs had a follow-up duplex and were included. Fifty-four percent of UEDVTs improved on the next duplex, 60% resolved before discharge, and 2% embolized. The internal jugular was the most common site (52%) and 72% were nonocclusive. Sixty-four percent were CAUEDVT's and line removal was associated with more frequent improvement on the next duplex (55% vs. 17%, p = 0.047, mid-P exact). Sixty-eight percent of UEDVTs were treated with some form of anticoagulation, but this was not associated with improved UE DVT resolution (61% vs. 60%). Independent predictors of clot resolution were location in the arm (odds ratio = 4.1 compared with the internal jugular, p = 0.031) and time from clot detection until final duplex (odds ratio =1.052 per day, p = 0.032).
A majority of UE DVT's are CA, more than half resolve before discharge, and 2% embolize. Anticoagulation does not appear to affect outcomes, but line removal does result in a quicker decrease in clot size.
上肢(UE)深静脉血栓形成(DVT)的自然病史及最佳治疗方法仍不明确,与导管相关(CA)的UE DVT的临床意义也不明确。我们试图分析UE DVT消退的预测因素,并假设抗凝治疗将与UE DVT血栓更快消退相关,且导管已拔除的CA UE DVT比非CA UE DVT更常消退。
对2008年1月至2010年5月在外科重症监护病房接受治疗的所有患者进行前瞻性随访。采用标准化的DVT预防方案,在入院后48小时内及之后每周进行双侧UE和下肢的双功超声检查以进行筛查。根据临床指征进行肺栓塞的计算机断层血管造影检查。UE DVT患者根据主治医生的判断进行治疗。记录有关患者人口统计学和UE DVT特征的数据:DVT部位、与导管的相关性、闭塞状态、治疗及消退情况。主要结局指标是出院前UE DVT的消退情况。还记录了UE DVT检测后后续双功超声检查中血栓大小的间隔缩小情况。未进行随访双功超声检查的UE DVT被排除在最终分析之外。采用单因素和多因素分析来确定UE DVT消退的独立预测因素。
129例患者中有201处UE DVT;123处DVT进行了随访双功超声检查并纳入分析。54%的UE DVT在下一次双功超声检查时有所改善,60%在出院前消退,2%发生栓塞。颈内静脉是最常见的部位(52%),72%为非闭塞性。64%为CA UE DVT,拔除导管与下一次双功超声检查时更频繁的改善相关(55%对17%,p = 0.047,精确中位P值)。68%的UE DVT接受了某种形式的抗凝治疗,但这与UE DVT消退改善无关(61%对60%)。血栓消退的独立预测因素是位于手臂(与颈内静脉相比,优势比 = 4.1,p = 0.031)以及从血栓检测到最后一次双功超声检查的时间(每天优势比 =1.052,p = 0.032)。
大多数UE DVT与导管相关,超过一半在出院前消退,2%发生栓塞。抗凝治疗似乎不影响结局,但拔除导管确实会使血栓大小更快减小。